Abstract
Signaling reactions on membranes play an important role in extracellular information processing by cells. The amount of signaling proteins on the plasma membrane is dynamically maintained by cells to tightly control the qualitative response properties of the signaling system. When oncogenic mutations occur in signaling proteins that are associated with the plasma membrane, the ensemble behavior of signaling molecules can change to a completely different response regime that changes the phenotype of the cell. In order to illuminate the relevance of this spatial dimension in signaling systems, we will first describe how the concentration of signaling proteins determines the qualitative response properties of simple reaction cycles in homogenous protein solutions. From there, we discuss how this concentration parameter is determined by the spatial distribution of proteins in cells and expand this to explain how the translocation of signaling proteins to membrane surfaces elicits a signaling response by changing their local concentration. Within this framework we then describe how an oncogene product’s interaction with its wild-type variant can lead to qualitatively different signaling behaviors that depend on their local concentration at membranes as maintained by spatially organizing reactions. We then argue that spatially organizing reaction systems provide an interesting target for cancer therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Niethammer P, Kronja I, Kandels-Lewis S, Rybina S, Bastiaens P, Karsenti E (2007) Discrete states of a protein interaction network govern interphase and mitotic microtubule dynamics. PLoS Biol 5(2):e29
Zamir E, Bastiaens PI (2008) Reverse engineering intracellular biochemical networks. Nat Chem Biol 4(11):643–647
Tyson JJ, Chen KC, Novak B (2003) Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. Curr Opin Cell Biol 15(2):221–231
Reynolds AR, Tischer C, Verveer PJ, Rocks O, Bastiaens PI (2003) EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation. Nat Cell Biol 5(5):447–453
Tischer C, Bastiaens PI (2003) Lateral phosphorylation propagation: an aspect of feedback signalling? Nat Rev Mol Cell Biol 4(12):971–974
Verveer PJ, Wouters FS, Reynolds AR, Bastiaens PI (2000) Quantitative imaging of lateral ErbB1 receptor signal propagation in the plasma membrane. Science 290(5496):1567–1570
Sorkin A, Goh LK (2008) Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res 314(17):3093–3106
Mosesson Y, Mills GB, Yarden Y (2008) Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer 8(11):835–850
Levkowitz G, Waterman H, Zamir E, Kam Z, Oved S, Langdon WY et al (1998) c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev 12(23):3663–3674
Bache KG, Slagsvold T, Stenmark H (2004) Defective downregulation of receptor tyrosine kinases in cancer. EMBO J 23(14):2707–2712
Axelrod D, Wang MD (1994) Reduction-of-dimensionality kinetics at reaction-limited cell surface receptors. Biophys J 66(3 Pt 1):588–600
Wu Y, Vendome J, Shapiro L, Ben-Shaul A, Honig B (2011) Transforming binding affinities from three dimensions to two with application to cadherin clustering. Nature 475(7357): 510–513
Chong H, Vikis HG, Guan K-L (2003) Mechanisms of regulating the Raf kinase family. Cell Signal 15(5):463–469
Kolch W (2000) Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 351(Pt 2):289–305
Slater SJ (2002) Regulation of PKCalpha activity by C1-C2 domain interactions. J Biol Chem 277:15277–15285
Freedman TS, Sondermann H, Friedland GD, Kortemme T, Bar-Sagi D, Marqusee S et al (2006) A Ras-induced conformational switch in the Ras activator son of sevenless. Proc Natl Acad Sci U S A 103(45):16692–16697
Gureasko J, Galush WJ, Boykevisch S, Sondermann H, Bar-Sagi D, Groves JT et al (2008) Membrane-dependent signal integration by the Ras activator son of sevenless. Nat Struct Mol Biol 15(5):452–461
Gureasko J, Kuchment O, Makino DL, Sondermann H, Bar-Sagi D, Kuriyan J (2010) Role of the histone domain in the autoinhibition and activation of the Ras activator Son of Sevenless. Proc Natl Acad Sci U S A 107(8):3430–3435
Zhao C, Du G, Skowronek K, Frohman MA, Bar-Sagi D (2007) Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos. Nat Cell Biol 9(6): 706–712
Sabouri-Ghomi M, Ciliberto A, Kar S, Novak B, Tyson JJ (2008) Antagonism and bistability in protein interaction networks. J Theor Biol 250(1):209–218
Hougland JL, Fierke CA (2009) Getting a handle on protein prenylation. Nat Chem Biol 5(4):197–198
Raymond FL, Tarpey PS, Edkins S, Tofts C, O’Meara S, Teague J et al (2007) Mutations in ZDHHC9, which encodes a palmitoyltransferase of NRAS and HRAS, cause X-linked mental retardation associated with a Marfanoid habitus. Am J Hum Genet 80(5):982–987
Hou H, John Peter AT, Meiringer C, Subramanian K, Ungermann C (2009) Analysis of DHHC acyltransferases implies overlapping substrate specificity and a two-step reaction mechanism. Traffic 10(8):1061–1073
Rocks O, Peyker A, Kahms M, Verveer PJ, Koerner C, Lumbierres M et al (2005) An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 307(5716): 1746–1752
Rocks O, Gerauer M, Vartak N, Koch S, Huang ZP, Pechlivanis M et al (2010) The palmitoylation machinery is a spatially organizing system for peripheral membrane proteins. Cell 141(3):458–471
Dudler T, Gelb MH (1996) Palmitoylation of Ha-Ras facilitates membrane binding, activation of downstream effectors, and meiotic maturation in Xenopus oocytes. J Biol Chem 271: 11541–11547
Misaki R (2010) Palmitoylated Ras proteins traffic through recycling endosomes to the plasma membrane during exocytosis. J Cell Biol 191:23–29
Dekker FJ, Rocks O, Vartak N, Menninger S, Hedberg C, Balamurugan R et al (2010) Small-molecule inhibition of APT1 affects Ras localization and signaling. Nat Chem Biol 6(6): 449–456
Chandra A, Grecco HE, Pisupati V, Perera D, Cassidy L, Skoulidis F et al (2012) The GDI-like solubilizing factor PDEdelta sustains the spatial organization and signalling of Ras family proteins. Nat Cell Biol 14(2):148–158
Nancy V (2002) The delta subunit of retinal rod cGMP phosphodiesterase regulates the membrane association of Ras and Rap GTPases. J Biol Chem 277(17):15076–15084
Leventis R, Silvius JR (1998) Lipid-binding characteristics of the polybasic carboxy-terminal sequence of K-ras4B. Biochemistry 37:7640–7648
Gomez GA, Daniotti JL (2007) Electrical properties of plasma membrane modulate subcellular distribution of KRas. FEBS J 274:2210–2228
Apolloni A (2000) H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway. Mol Cell Biol 20:2487
Silvius JR (2006) K-ras4B and prenylated proteins lacking “second signals” associate dynamically with cellular membranes. Mol Biol Cell 17:192–202
Shibata Y, Shemesh T, Prinz WA, Palazzo AF, Kozlov MM, Rapoport TA (2010) Mechanisms determining the morphology of the peripheral ER. Cell 143(5):774–788
Ismail SA, Chen YX, Rusinova A, Chandra A, Bierbaum M, Gremer L et al (2011) Arl2-GTP and Arl3-GTP regulate a GDI-like transport system for farnesylated cargo. Nat Chem Biol 7(12):942–949
Zhou C, Cunningham L, Marcus AI, Li Y, Kahn RA (2006) Arl2 and Arl3 regulate different microtubule-dependent processes. Mol Biol Cell 17(5):2476–2487
Sharma SV, Settleman J (2007) Oncogene addiction: setting the stage for molecularly targeted cancer therapy. Genes Dev 21(24):3214–3231
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70
Aksamitiene E (2012) Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance. Biochem Soc Trans 40:139–146
Deramaudt T, Rustgi AK (2005) Mutant KRAS in the initiation of pancreatic cancer. Biochim Biophys Acta 1756:97–101
Luwor RB, Lu Y, Li X, Liang K, Fan Z (2011) Constitutively active Harvey Ras confers resistance to epidermal growth factor receptor-targeted therapy with cetuximab and gefitinib. Cancer Lett 306(1):85–91
Aoki Y (2005) Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet 37:1038–1040
Verdine GL, Walensky LD (2007) The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members. Clin Cancer Res 13(24):7264–7270
Brunner TB, Hahn SM, Gupta AK, Muschel RJ, McKenna WG, Bernhard EJ (2003) Farnesyltransferase inhibitors. Cancer Res 63(18):5656–5668
Downward J (2003) Targeting RAS, signalling pathways in cancer therapy. Nat Rev Cancer 3(1):11–22
Ferrell JE Jr (2009) Signaling motifs and Weber’s law. Mol Cell 36(5):724–727
Goentoro L, Kirschner MW (2009) Evidence that fold-change, and not absolute level, of beta-catenin dictates Wnt signaling. Mol Cell 36(5):872–884
Groves JT, Kuriyan J (2010) Molecular mechanisms in signal transduction at the membrane. Nat Struct Mol Biol 17:659–665
Guerra C, Collado M, Navas C, Schuhmacher AJ, Hernandez-Porras I, Canamero M et al (2011) Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 19(6):728–739
Zhang H, Li S, Doan T, Rieke F, Detwiler PB, Frederick JM et al (2007) Deletion of PrBP/delta impedes transport of GRK1 and PDE6 catalytic subunits to photoreceptor outer segments. Proc Natl Acad Sci U S A 104(21):8857–8862
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Zamir, E., Vartak, N., Bastiaens, P.I.H. (2013). Oncogenic Signaling from the Plasma Membrane. In: Yarden, Y., Tarcic, G. (eds) Vesicle Trafficking in Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6528-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6528-7_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6527-0
Online ISBN: 978-1-4614-6528-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)